| ALC |
absolute lymphocyte count |
| ANC |
absolute neutrophil count |
| BMB |
bone marrow biopsy |
| BMT |
bone marrow transplant (see specifics listed above) |
| B2M |
beta 2 microglobulin test. Beta-2-microglobulin is a protein found on all the surface of all cells and small amounts are shed into the serum. People diagnosed with blood diseases and who have levels of beta-2-microglobulin below 2.0 seem to have a longer survival rate. |
| Bx |
biopsy |
| B/P |
blood Pressure |
| CBC |
complete blood count |
| CCDRT |
cell culture drug resistance testing |
| CD |
cluster of differentiation |
| Cnet |
Cancernet (where one gets PDQ and Cancer Lit papers)
|
| CR |
complete remission
|
| CRN |
complete remission with nodular pattern in marrow
|
| CS |
clinical Stage
|
| DLI |
donor lymphocyte infusion |
| Dx |
diagnosis
|
| EORTC |
European Organization for Research and Treatment of Cancer
|
| FISH |
Fluorescence In Situ Hybridization. It is a test used to detect chromosome abnormalities in cells and has been used to test lymphocytes in CLL. The results help to predict the prognosis for a particular patient.
|
| GP |
General Practitioner: Doctor within NHS (UK)
|
| GVHD |
graft versus host disease
|
| GVL |
graft versus leukemia or graft versus lymphoma
|
| HCT |
hematocrit-the percentage of red blood cells in the blood. A low hematocrit measurement indicates anemia.
|
| HDC |
high dose chemotherapy--often used to condition one before a BMT or PBSCT
|
| Hem/Onc |
hematologist/oncologist
|
| HGB |
hemoglobin
|
| HLA |
Human leukocyte antigen test. A special blood test used to match a blood or bone marrow donor to a recipient for transfusion or transplant.
|
| Ig |
Immunoglobulin (IgA, IgD, IgE, IgG, IgM)
|
| IV |
intravenous--into a vein
|
| Mab or MoAb |
monoclonal antibodies (i.e. Campath-1H, Rituxan, Bexxar)
|
| MD |
Medical Doctor (USA)
|
| MLUS |
monoclonal lymphocytosis of undetermined significance |
| MUD |
matched unrelated donor of bone marrow
|
| NMDP |
National Marrow Donor Program --1-800-526-7809
|
| NR |
nodular remission (nodules of cancer cells remain in the marrow, but there are less than 10% cancer cells throughout)
|
| OR |
overall remission
|
| PCP |
primary care physician
|
| PDQ |
physicians data query
|
| PHN |
postherpetic neuralgia
|
| PR |
partial remission
|
| RBC |
red blood count
|
| RX |
prescribed medication
|
| SWOG |
Southwest Oncology Group
|
| TBI |
Total body irradiation
|
| WBC |
white blood count
|
| WBC/HPF |
white blood cells counted per high powered field
|
| WD |
well differentiated
|
| WW |
watch and wait (also called, watch and worry)
|
| XRT |
external radiation therapy
|
| AA |
aplastic anemia
|
| AIHA |
autoimmune hemolytic anemia |
| ALL |
acute lymphocytic leukemia (+3 subtypes according to morphology. L1-L3 and subtypes according to phenotype: T, pre-B, pre-pre-B, B)
|
| AML |
acute myelogeneous leukemia (+8 subtypes MO-M6)
|
| AMM |
agnogenic myeloid metaplasia
|
| AMML |
acute myelogeneous leukemia
|
| ANLL |
acute non-lymphocytic leukemia (same as AML above)
|
| APL |
acute prolymphocytic leukemia
|
| APML |
acute promyelocytic leukemia
|
| BCP-ALL |
B-cell precursor acute lymphoblastic leukemia
|
| CLL |
chronic lymphocytic leukemia
|
| CML |
chronic myeloid leukemia (each has subtypes)
|
| CMML |
chronic myelomonocytic leukemia
|
| CNSL |
central nervous system lymphoma
|
| ET |
essential thrombocythemia
|
| HCL |
hairy cell leukemia
|
| HD |
Hodgkins lymphoma (4 subtypes)
|
| ITP |
idiopathic thrombocytopenic purpura |
| MCH |
mean corpuscular hemoglobin
|
| MCHC |
mean corpuscular hemoglobin concentration
|
| MCL |
mantle cell lymphoma
|
| MCV |
mean corpuscular volume
|
| MDS |
myelodysplastic syndrome (4 subtypes)
|
| MF |
mycosis fungoides (cutaneous T-cell lymphoma)
|
| MM |
multiple myeloma
|
| MPD |
myeloproliferative disorders
|
| MRD |
minimal residual disease
|
| NHL |
non-Hodgkins lymphoma (many subtypes)
|
| PCR |
polymerase chain reaction
|
| PLL |
prolymphocytic leukemia |
| PV |
polycythemia vera
|
| RDW |
red cell distribution width
|
| SLL |
small lymphocytic lymphoma
|
| SLVL |
splenic lymphoma with villous lymphocytes
|
| TRM |
treatment-related mortality
|
| WM |
Waldenstrom's Macroglobulinemia
|
| ABVD |
doxorubicin, vinblastine, bleomycin, DTIC
|
| ACOB |
doxorubicin, cyclophosphamide, vincristine, bleomycin
|
| ARA-C |
cytarabine
|
| ATRA |
all-trans retinoic acid, or Vesanoid
|
| BACOP |
bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone
|
| BEAM |
busulfan, etoposid, ara-c, melphalan
|
| BLEO |
bleomycin
|
| 2CdA |
2-chlorodeoxyadenosine (Generic name = cladribine)
|
| C-MOPP |
cyclophosphamide, oncovin, procarbazine, prednisone
|
| CCNU |
(1-2-chloroethyl)-3-cyclohexyl-1-nitrosourea)
|
| CHOD |
cyclophosphamide, doxorubicin, vincristine, dexamethasone
|
| CHOP |
cyclophosphamide, adriamycin, vincristine, prednisone
|
| CHOP-BLEO |
cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin
|
| CMF |
cyclophosphamide, methotrexate, fluorouacil
|
| COP |
cyclophosphamide, oncovin, prednisone
|
| COPP |
CCNU, vincristine,procarbazine, prednisone
|
| CyA |
cyclosporin A
|
| CVP |
cyclophosphamide, vincristine, prednisone
|
| DCF |
2-deoxycoformycin (pentostatin)
|
| DTIC |
dacarbazine, 5-(3,3-dimethyl-1-triazino)imidazole-4-carboxamide
|
| EPOCH |
etopside, prednisone, vincristine, cyclophosphamide (cytoxan), adriamycin
|
| ESHAP |
etopside (VP-16), methylprednisolone (SOL), cytarabine (AraC), cisplatin (CDDP) and prednisone (Pred)
|
| FAC |
fluorouacil, adriamycin, cyclophosphamide
|
| FCR |
fludarabine, cyclophosphamide, rituxan |
| Flu |
fludarabine (Fludara)
|
| IFN |
Interferon (comes in alpha2a, alpha 2b, human leukocyte, and beta--Another one "concensus" is still in trials)
|
| IL |
Interleuken
|
| mBACOD |
methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, dexamethasone
|
| MOPP |
nitrogen mustard, vincristine, procarbazine, prednisone
|
| MTX or M |
methotrexate
|
| proMACE |
prednisone, methotrexate with leukovorin rescue, doxorubicin, cyclophosphamide, etoposide (VP-16)
|
| RFC |
rituximab, fludarabine, cyclophosphamide
|
| ACRC |
Arkansas Cancer Research Center
|
| Brigham |
Brigham and Women's Hospital, Boston, MA
|
| DFCI |
Dana Farber Cancer Institute, Boston, MA
|
| FHCRC or the Hutch |
Fred Hutchinson Cancer Research Center, Seattle, WA
|
| JH |
Johns Hopkins Medical Center, Baltimore, MD
|
| MDACC |
MD Anderson Cancer Center, Houston, TX
|
| MSK or MSKCC |
Memorial Sloan-Kettering Cancer Center, NYC, NY
|
| NCI |
National Cancer Institute, Bethesda, MD
|
| Roswell |
Roswell Park Cancer Center in Buffalo, NY
|
| Strong |
Strong Memorial Cancer Center at Univ. of Rochester, NY
|
